Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Cenix and Instituto de Medicina Molecular, AstraZeneca and Cellectricon, Kreatech Biotechnology and Ambion, National Institute of Advanced Industrial Science and Technology in Tokyo

Cenix and Instituto de Medicina Molecular, AstraZeneca and Cellectricon, Kreatech Biotechnology and Ambion, National Institute of Advanced Industrial Science and Technology in Tokyo

Jul 04, 2005
Premium

Cenix, IMM Develop RNAi Screen for Malaria; Seek Funding for Larger Assay

Researchers at the Instituto de Medicina Molecular in Lisbon, Portugal, and Cenix Bioscience hjave developed an RNAi screen for malaria genes that may lead to better anti-malarial therapeutics, IMM and Cenix said last week in a statement.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Germany to Increase Viral Sequencing

Reuters reports that Germany is seeking to sequence 5 percent of patient samples that test positive for SARS-CoV-2.

Getting Used to It

23andMe and Medscape say primary care physicians are increasingly more comfortable with discussing direct-to-consumer genetic testing results.

Green Access at Science

The publisher of the Science family of journals will allow some authors to place peer-reviewed versions of their papers into publicly accessible repositories.

Science Papers Examine Chronic Kidney Disease GWAS, Pneumonia Microbiome

In Science this week: analysis of genome-wide association studies of chronic kidney disease, and more.

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.